WallStSmart

Cerence Inc (CRNC)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cerence Inc generates 22% more annual revenue ($315.96M vs $258.90M). CRNC leads profitability with a 0.1% profit margin vs -15.5%. CRNC earns a higher WallStSmart Score of 52/100 (C-).

CRNC

Buy

52

out of 100

Grade: C-

Growth: 4.7Profit: 6.0Value: 5.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRNCUndervalued (+71.7%)

Margin of Safety

+71.7%

Fair Value

$28.66

Current Price

$9.10

$19.56 discount

UndervaluedFair: $28.66Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRNC3 strengths · Avg: 9.3/10
Operating MarginProfitability
32.2%10/10

Strong operational efficiency at 32.2%

Revenue GrowthGrowth
126.1%10/10

Revenue surging 126.1% year-over-year

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

CRNC4 concerns · Avg: 2.8/10
Market CapQuality
$393.46M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.3%3/10

ROE of 0.3% — below average capital efficiency

Profit MarginProfitability
0.1%3/10

0.1% margin — thin

P/E RatioValuation
437.0x2/10

Premium valuation, high expectations priced in

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : CRNC

The strongest argument for CRNC centers on Operating Margin, Revenue Growth, Price/Book. Revenue growth of 126.1% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : CRNC

The primary concerns for CRNC are Market Cap, Return on Equity, Profit Margin. A P/E of 437.0x leaves little room for execution misses. Thin 0.1% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

CRNC carries more volatility with a beta of 2.73 — expect wider price swings.

CRNC is growing revenue faster at 126.1% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRNC scores higher overall (52/100 vs 41/100) and 126.1% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cerence Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Cerence Inc. provides assistants and innovations with artificial intelligence technology for connected and autonomous vehicles. Offers state-of-the-art software components; components connected to the cloud; tool kits; Applications; and virtual assistant for coexistence and professional services. The company is headquartered in Burlington, Massachusetts.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?